Chinese Traditional and Herbal Drugs
|
2025, 56(17): 6439-6449
Research progress on pharmacological mechanism of Lycium barbarum polysaccharides in Alzheimer’s disease
Full
YANG Haolin1, HUANG Yating1, ZHAO Ruomei1, YOU Kexin1, YIN Di1, XU Anran1, YANG Fei2
Affiliations
1 Clinical Medical College, North Sichuan Medical College, Nanchong 637000, China; 2 Department of Neurology, Affiliated Hospital of North Sichuan Medical College, Nanchong 637000, China
About Author:
四川省基层卫生中心项目 (SWFZ24-Y-70); 南充市社会科学界联合会项目 (NC25B240); 川北医学院博士启动基金 (CBY23-QDA29)
doi: 10.7501/j.issn.0253-2670.2025.17.031
Outline
Alzheimer’s disease (AD) is a neurodegenerative disorder of the central nervous system characterized by progressive deterioration of learning and memory functions. With the intensification of population aging, the incidence of AD continues to rise annually, posing a significant public health threat. Currently, the pathogenesis of AD remains incompletely elucidated, and clinically effective treatments are still lacking. Traditional Chinese medicine (TCM), with its characteristic multi-component composition and multi-target activity, offers advantages in treating complex multifactorial diseases. Studies indicate that Lycium barbarum polysaccharide (LBP), the primary active component of Gouqizi (Lycii Fructus), exhibits promising therapeutic potential for AD through its effects including anti-inflammatory, anti-apoptotic, mitochondrial protective, and anti-oxidant properties and functions of inhibiting β-amyloid (Aβ) abnormal deposition and Tau protein hyperphosphorylation, regulating neurotransmitter, restoring synaptic plasticity, modulating the microbiota-gut-brain axis, and improving insulin resistance, contributing to AD prevention and treatment. This study analyzes the pharmacological mechanisms underlying LBP’s therapeutic effects in AD, providing a reference for future research on the prevention and treatment of AD by LBP.
Lycium barbarum polysaccharide
/
Alzheimer’s disease
/
amyloid β
/
Tau protein
/
neuroinflammation
/
insulin resistance
杨昊霖, 黄雅婷, 赵若梅, 游可欣, 尹迪, 徐安然, 杨飞.
枸杞多糖在阿尔茨海默病中药理作用机制研究进展.
中草药,
2025
, 56
(17)
: 6439
-6449
.
DOI: 10.7501/j.issn.0253-2670.2025.17.031
YANG Haolin, HUANG Yating, ZHAO Ruomei, YOU Kexin, YIN Di, XU Anran, YANG Fei.
Research progress on pharmacological mechanism of Lycium barbarum polysaccharides in Alzheimer’s disease[J].
Chinese Traditional and Herbal Drugs,
2025
, 56
(17)
: 6439
-6449
.
DOI: 10.7501/j.issn.0253-2670.2025.17.031
Year 2025 volume 56 Issue 17
44
0
Cite this Article
BibTeX
Article Info
doi: 10.7501/j.issn.0253-2670.2025.17.031
- Receive Date:2025-04-03
- Online Date:2026-11-12